Long-term complications of type 1 diabetes: what do we know and what do we need to understand?

Minerva Pediatr (Torino). 2021 Dec;73(6):504-522. doi: 10.23736/S2724-5276.21.06545-9. Epub 2021 Sep 16.

Abstract

Long-term complications of type 1 diabetes (T1D) include microvascular complications and macrovascular disease. Despite the important advances in the treatment of T1D of the last decades, these complications still represent the leading cause of morbidity and mortality in patients with T1D. Extensive evidence indicates that structural and functional alterations of the kidney, retina, nerves and large arteries occur already in the first years after the onset of diabetes. We performed a comprehensive review of the available evidence on screening, diagnosis, prevention and treatment of vascular complications of T1D. In particular, we focused on three major challenges related to long-term complications of T1D: 1) finding of new biomarkers and diagnostic methods able to identify early signs of complications; 2) identifying specific risk factors for the development of these complications; 3) identifying and implementing new therapeutic strategies able to prevent the development and progression of vascular complications.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Cardiovascular Diseases*
  • Diabetes Mellitus, Type 1*
  • Humans
  • Mass Screening
  • Risk Factors

Substances

  • Biomarkers